Navigation Links
Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia

ICAL NOTES FOR EDITORS

Chronic Lymphocytic Leukaemia

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in adults in western Europe and North America, new cases occurring at an annual incidence of 3 to 5 per 100,000 persons in the population. The condition occurs primarily in older people with a median age at diagnosis of 66 years. Men are twice as likely as women to develop the disease. The clinical course of the condition varies widely with some patients showing rapid disease progression and early death, despite intensive chemotherapy, and others surviving for decades without any treatment. CLL is characterised by excessive numbers of functionally incompetent long-lived B-lymphocytes (small white blood cells) circulating in the blood, sometimes also causing swelling of lymph nodes, spleen and other organs. The failure of these cancerous B-CLL cells to die is generally thought to be due at least in part to over expression of the Bcl-2 gene characteristic of the disease.

About Bcl-2

The protein Bcl-2, first identified in B-cell lymphoma/leukaemia cells from which its name derives, is one of a family of intracellular proteins regulating cell survival and cell death. Some types of cells in the body, for example blood cells, are programmed to die after a few weeks of life, in the case of blood cells to be replaced in the circulation by fresh cells produced in the bone marrow. This process of programmed cell death is known as apoptosis. Bcl-2 is an apoptosis suppressor protein, i.e. it extends the lifespan of the cell in the presence of normal apoptosis stimuli. The levels of Bcl-2 within the cell are frequently over-expressed in malignant cancers, and this is particularly the case in human chronic lymphocytic leukaemia and lymphoma where it acts to prolong the life of malignant white blood cells. Drugs which lower the concentration of Bcl-2 or inhibit its function may therefore have therapeutic benefit by inducing cance
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:9/15/2014)... Pa. , Sept. 15, 2014 /PRNewswire-iReach/ -- ... -based biotechnology company developing calcium phosphate (CaP)-based nanoparticle ... the company has entered a License Agreement with ... biotechnology company developing immunotherapy products for the treatment ... Under the terms of the agreement, ...
(Date:9/15/2014)... , Sept. 15, 2014  Over 200 ... one roof Saturday to learn, interact and participate ... York City,s first Lupus Trials Fair launched by ... the S.L.E. Lupus Foundation .  Attendees interacted ... institutions -- sharing experiences, ideas and needs and ...
(Date:9/15/2014)... LINCOLNSHIRE, Ill. , Sept. 15, 2014 /PRNewswire/ ... testing equipment and information systems technology, announced today ... (LABSCO).  This agreement is for Sysmex reagents, controls ... Sysmex pocH-100 i ™ , Sysmex XP-300™, ... The agreement is effective immediately and continues ...
Breaking Medicine Technology:CaPtivate Pharmaceuticals Enters License Agreement With Immunotope 2CaPtivate Pharmaceuticals Enters License Agreement With Immunotope 3Lupus Research Institute Launches NYC's First Lupus Trials Fair 2Lupus Research Institute Launches NYC's First Lupus Trials Fair 3Sysmex America, Inc. Renews LABSCO Distributorship 2Sysmex America, Inc. Renews LABSCO Distributorship 3
... July 14 Samsung Medical Center and the world,s leading bio-pharmaceutical company ... research partnership to jointly analyze tumors from Korean patients to generate gene expression ... patients with liver cancer. , , ... http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO ) , , , ...
... , SANTA ROSA, Calif. , July 14 ... Santa Rosa, California , today received a notice of ... company which was started in 2006 has thirteen additional patent ... the world for related spinal therapies and devices. The lead ...
Cached Medicine Technology:Pfizer and SMC Collaborate on Liver Cancer 2Pfizer and SMC Collaborate on Liver Cancer 3Osseon Receives Patent Allowance for Novel Spinal VCF Treatment Devices 2
(Date:9/15/2014)... The Best Hospitals Honor Roll ... of seven hospitals using OnBase as their enterprise ... Clinic were ranked at the top of the list, ... cover nearly 5,000 medical centers across the country with ... scored highest in at least six of the sixteen ...
(Date:9/15/2014)... Dotinga HealthDay Reporter , ... cholesterol-lowering drugs are more likely to fill their prescriptions ... generic brands, new research suggests. At issue are ... Crestor, Zocor and Lipitor. Generic statins are also available. ... heart problems due to clogged arteries. About ...
(Date:9/15/2014)... The White House has recently begun shifting ... jail and prison and toward helping them access addiction ... positive change. , The nation is currently grappling with ... to an article from The Washington Post , ... away from using the criminal justice system to address ...
(Date:9/15/2014)... Dennis Thompson ... News) -- The severe respiratory virus believed to have ... states has now spread to the Northeast, health officials ... confirmed on Friday more than a dozen cases of ... for children with asthma. And on Saturday, the ...
(Date:9/15/2014)... Array Health , an independent ... that Independence Blue Cross (Independence), the ... selected the Array Spectrum™ Private Exchange solution for ... employers with more than 100 employees. Using the ... offer employer groups a comprehensive selection of products ...
Breaking Medicine News(10 mins):Health News:Seven of Top Ten Hospitals in the U.S. Leverage OnBase by Hyland ECM Solution 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 3Health News:White House Shifts Policy on Drugs 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 2Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 3
... to press ahead or wait; job creation is public,s top ... of Americans want some kind of health reform in the ... a good thing if the legislation proposed by the Democrats ... if health reform would be good or bad for the ...
... , , FAIRFIELD, N.J. , Feb. 11 ... without the right footwear. And the actual surface for the ... Athletic™ lineup of portable fitness mats and interlocking gym flooring ... basic stretching, Shock Athletic products offer a broad range of ...
... , ... a lawyer with the Louthian Law Firm in Columbia, S.C., says developments in lawsuits ... cannot seek justice. , ... Columbia, South Carolina (PRWEB) February 11, 2010 -- The anti-smoking patch Chantix continues ...
... ... panic as the long-term shortage of Armour Thyroid, Nature-Throid, and Westhroid continues. The ... is a little-known secret that thousands of Americans have already discovered. There is ... ...
... ... Humber NHS Framework, in addition to two in Dec & Jan, with Acute & Mental ... , ... 11, 2010 -- BigHand, a leading provider of voice technology to the healthcare market, has ...
... , DENVER, CO , Feb. 10 ... ( MIT ) is pleased to announce that its ... the production certification to produce Med-Jet products in China ... subject of a recent visit by the SFDA. These facilities ...
Cached Medicine News:Health News:Poll Shows Eroding Support for Health Reform 2Health News:Poll Shows Eroding Support for Health Reform 3Health News:Poll Shows Eroding Support for Health Reform 4Health News:For a Healthier, Cleaner Fitness Regimen - Venture Products' Shock Athletic(TM) Mats and Interlocking Flooring 2Health News:For a Healthier, Cleaner Fitness Regimen - Venture Products' Shock Athletic(TM) Mats and Interlocking Flooring 3Health News:South Carolina Attorney Says Legal Options Still Available To Those Harmed By Chantix 2Health News:South Carolina Attorney Says Legal Options Still Available To Those Harmed By Chantix 3Health News:No End In Sight To The Armour Thyroid Shortage? 2Health News:No End In Sight To The Armour Thyroid Shortage? 3Health News:Three NHS Trusts Choose BigHand Voice Technology Under YHCPC Framework Agreement 2Health News:Major milestone achieved by our joint venture in China 2Health News:Major milestone achieved by our joint venture in China 3
... SF (slot format) microfiltration units provide a ... acid in solution onto nitrocellulose or Zeta-Probe ... by using interchangeable templates to form the ... Bio-Dot SF apparatus. Each is available as ...
Dot Blotter - 96-Well Dot Blot...
... base with vacuum stage, porous vacuum plate, reservoir ... instructions. The Model 785 vacuum blotter quickly ... agarose gel onto a nylon membrane. Because it ... nucleic acid samples can be separated on a ...
Mini Trans-Blot and PowerPac 300 System, 110-120 V...
Medicine Products: